Stay updated on Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, replacing the previous Revision: v3.6.4. This indicates a minor site update rather than changes to study data.
    Difference
    0.0%
    Check dated 2026-08-08T22:42:45.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page's revision label was updated from v3.6.3 to v3.6.4, indicating a newer version of the published content.
    Difference
    0.0%
    Check dated 2026-07-25T13:06:29.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    The study page now indicates that results have been submitted, replacing the previous 'No Results Posted' status and signaling that results are in the submission/verification process for this trial.
    Difference
    0.0%
    Check dated 2026-07-18T09:23:47.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a minor maintenance update rather than any changes to the study data.
    Difference
    0.0%
    Check dated 2026-07-03T23:59:56.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Revision: v3.6.2 replaces the previous v3.6.0 on the page, reflecting a newer site version. This is a technical update and does not alter the study content or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-27T01:14:28.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The page now shows a recruitment-status update, indicating enrollment is closed, and adds new help sections (How to Read a Study Record, Common Questions, How to Join a Study) along with an Intervention/Treatment labeling change, while removing the old 'Intervention / Treatment' label and the prior 'Revision: v3.5.5' note.
    Difference
    0.4%
    Check dated 2026-06-12T14:18:34.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab in Renal Cell Carcinoma Clinical Trial page.